|
Centre for Policy on Ageing | |
 | |
|
Alzheimer's disease health economics summaries | Corporate Author | Novartis Pharmaceuticals UK |
Publisher | Novartis Pharmaceuticals UK, Camberley, 1997 |
Pages | 15 pp |
Source | Novartis Pharmaceuticals UK Ltd., Frimley Business Park, Frimley, Camberley, Surrey GU16 5SG. |
Keywords | Dementia ; Social economics ; Costs [care] ; Family care ; Hospital services ; Nursing homes ; Research Reviews. |
Annotation | This pamphlet brings together some of the important health economic work undertaken on the care of patients with Alzheimer's disease (AD). It aims to highlight some of the key issues resulting from that research, to provide information in an accessible form to those seeking to improve the quality of care, and to engage discussion on clinical and economic bench marks. Papers are presented on the impact of symptom severity, the burden of illness, the unpaid burden of caring, the economic burden of AD care, costs of institutional care, and economic costs. |
Accession Number | CPA-980317206 B |
Classmark | EA: W4: QDC: P6:SJ: LD: LHB: 3A:6KC * |
Data © Centre for Policy on Ageing |
|
...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|